Ex parte HEMPRECHT - Page 6




          Appeal No. 1997-2195                                                        
          Application 08/102,752                                                      



               Hamprecht ‘927 discloses pyrimidines which are useful as               
          intermediates for crop protecting agents (col. 6, lines 65-68).             
          These pyrimidines differ from those of appellant in that at the             
          6-position, the Hamprecht ‘927 pyrimidines have an -OR  group,2                     
          where R  is alkyl, alkenyl, alkynyl, cycloalkyl, phenyl or benzyl2                                                                    
          (col. 1, lines 5-21), rather than having appellant’s                        
          trifluoromethoxy group.                                                     
               The examiner argues that it would have been obvious to one             
          of ordinary skill in the art to substitute a trifluoromethoxy               
          group for the methoxy group in Hamprecht’s example 1 because                
          Lacchein (table, page 10) teaches the equivalence of methoxy and            
          trifluoromethoxy substituents in a pyrimidine in an analogous art           
          (answer, page 4).  The examiner, however, does not explain how              
          one of ordinary skill in the art would have formed the                      
          trifluoromethoxy substituent.  As discussed above, the Hamprecht            
          declaration indicates that one of ordinary skill in the art could           
          not have formed such a substituent using Lacchein’s method, and             
          the examiner has presented no evidence or technical reasoning to            
          the contrary.  Accordingly, we conclude that the examiner has not           
          established a prima facie case of obviousness of appellant’s                

                                           6                                          





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  Next 

Last modified: November 3, 2007